AUM Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- AUM Biosciences's estimated annual revenue is currently $4.2M per year.
- AUM Biosciences's estimated revenue per employee is $155,000
Employee Data
- AUM Biosciences has 27 Employees.
- AUM Biosciences grew their employee count by 0% last year.
AUM Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder, CEO | Reveal Email/Phone |
AUM Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.9M | 24 | -40% | $19.2M | N/A |
#2 | $6M | 39 | -49% | N/A | N/A |
#3 | $8.5M | 55 | 62% | N/A | N/A |
#4 | $1.7M | 11 | -45% | N/A | N/A |
#5 | $3M | 39 | -13% | $80M | N/A |
#6 | $4.2M | 27 | 0% | N/A | N/A |
#7 | $28.2M | 182 | -24% | $220M | N/A |
#8 | $4.5M | 29 | 4% | N/A | N/A |
#9 | $3.6M | 23 | -34% | N/A | N/A |
#10 | $3.3M | 43 | -22% | $51.2M | N/A |
What Is AUM Biosciences?
AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. 1) MNK Inhibition and 2) Multi-Kinase Inhibition (PIM/PI3K/mTOR). AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM's most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation. For 2 years in a row, the company has been awarded the Frost & Sullivan Asia-Pacific Biotech Entrepreneurial Company of the Year Award.
keywords:N/AN/A
Total Funding
27
Number of Employees
$4.2M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
AUM Biosciences News
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies. AUM has an...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 27 | 4% | N/A |
#2 | $3.9M | 27 | N/A | N/A |
#3 | $5.4M | 27 | N/A | N/A |
#4 | $2.6M | 27 | -23% | N/A |
#5 | $2.6M | 27 | N/A | N/A |